发明名称 1H-QUINAZOLINE-2,4-DIONES
摘要 FIELD: chemistry.SUBSTANCE: invention relates to N-[2,4-dioxo-6-(tetrahydrofuran-2-yl)-7-trifluoromethyl-1,4-dihydro-2H-quinazolin-3-yl]methanesulphonamide and N-[6-(1-isopropoxyethyl)-2,4-dioxo-7-trifluoromethyl-1,4-dihydro-2H- quinazolin-3-yl] methanesulphonamide, having antagonistic activity on the AMPA receptor. The invention also relates to a pharmaceutical composition.EFFECT: use of said compounds to produce drugs for treating AMPA mediated conditions and primarily for treating epilepsy or schizophrenia.6 cl, 81 ex
申请公布号 RU2509764(C2) 申请公布日期 2014.03.20
申请号 RU20110131276 申请日期 2006.04.10
申请人 NOVARTIS AG 发明人 ALL'GAJER KHANS;OBERSON IV;KARKASH DAVID;FLERSHAJM FILIPP;GIBURDENSH KRISTEL';FRESHTL' VOL'FGANG;KALLEN JERG;KOLLER MANUEHL';MATTE ANRI;NOTSULAK JOAKHIM;OREN DAVID;RENO ZHOANNE
分类号 C07D239/96;A61K31/517;A61P25/08;A61P25/18;C07C229/56;C07C229/64;C07C229/66;C07C255/18;C07C265/12;C07D207/32;C07D207/337;C07D231/12;C07D237/08;C07D239/26;C07D241/12;C07D249/06;C07D263/32;C07D307/16;C07D307/54;C07D309/12;C07D401/04;C07D403/04;C07D405/04;C07D413/04 主分类号 C07D239/96
代理机构 代理人
主权项
地址